Autoimmune Diseases Associated with Eosinophilia of 9.9%
An eosinophil percentage of 9.9% (representing moderate eosinophilia) should prompt evaluation primarily for eosinophilic granulomatosis with polyangiitis (EGPA), followed by consideration of autoimmune hepatitis, rheumatoid arthritis, inflammatory bowel disease, and IgG4-related disease.
Primary Autoimmune Consideration: EGPA
EGPA (Churg-Strauss syndrome) is the most important autoimmune vasculitis to consider with this level of eosinophilia 1. This small-vessel vasculitis characteristically presents with:
- Asthma (often severe and late-onset)
- Eosinophilia (peripheral blood and tissue)
- Rhinosinusitis with nasal polyps
- Lung infiltrates on imaging
ANCA Testing is Critical
ANCA positivity occurs in 30-40% of EGPA patients, predominantly MPO-ANCA (P-ANCA pattern) 1. The ANCA status predicts clinical phenotype:
- MPO-ANCA positive patients: More likely to have glomerulonephritis, peripheral neuropathy, purpura, and renal involvement
- ANCA-negative patients: More frequently manifest cardiomyopathy and lung involvement, with worse overall survival due to cardiac complications 1
Important caveat: Isolated P-ANCA positivity without MPO-ANCA can occur in other inflammatory conditions like inflammatory bowel disease, so enzyme-linked immunosorbent assay for MPO-ANCA is the reference test 1.
Other Autoimmune Diseases with Eosinophilia
Autoimmune Hepatitis
Acute or subacute hepatitis with peripheral eosinophilia, hypergammaglobulinemia, and positive autoantibodies can present with this degree of eosinophilia 2. Look for elevated transaminases and liver-specific autoantibodies.
Rheumatoid Arthritis
The coexistence of eosinophilia with rheumatoid arthritis has been documented, particularly when associated with chronic eosinophilic pneumonia 3. Recent data shows RA as one of the more common autoimmune associations (1% prevalence in eosinophilic cohorts) 1.
Inflammatory Bowel Disease
Can present with isolated P-ANCA positivity and eosinophilia, though this is typically a non-vasculitic manifestation 1.
IgG4-Related Disease
Should be considered as it can occasionally present with eosinophilia and has overlapping features with EGPA 1.
Risk Stratification and Prognosis
Recent large-scale data demonstrates that eosinophilia at this level carries significant prognostic implications 4:
- Adults: Increased risk of hematologic malignancy (HR 2.86), autoimmune disease (HR 1.64), thromboembolic events (HR 1.91), and mortality (HR 2.20)
- Children: Even more pronounced risks including solid tumors (HR 14.24), autoimmune disease (HR 2.48), and markedly increased mortality (HR 7.95)
Diagnostic Algorithm
For eosinophilia of 9.9% with suspected autoimmune etiology:
- Assess for EGPA clinical triad: asthma, rhinosinusitis, eosinophilia
- Order ANCA testing: Both immunofluorescence and MPO-ANCA/PR3-ANCA by ELISA
- Evaluate organ involvement:
- Pulmonary function tests and chest imaging
- Urinalysis and renal function (glomerulonephritis)
- Cardiac evaluation if symptoms present (cardiomyopathy risk)
- Nerve conduction studies if neuropathy suspected
- Screen for other autoimmune markers: ANA, RF, liver function tests, inflammatory markers
- Consider tissue biopsy if diagnosis remains unclear: skin, lung, or affected organ showing necrotizing vasculitis with eosinophilic infiltration
Critical Pitfalls to Avoid
- Do not dismiss isolated P-ANCA positivity without confirming MPO-ANCA status, as it may represent inflammatory bowel disease rather than vasculitis 1
- Do not overlook cardiac involvement in ANCA-negative patients, as this drives mortality risk 1
- Do not assume all eosinophilia is allergic: At 9.9%, this warrants systematic autoimmune evaluation given the significant mortality associations 4
- Do not delay evaluation: Severe eosinophilia is a strong prognostic marker requiring comprehensive assessment and close follow-up 4